Product logins

Find logins to all Clarivate products below.


ENT Devices | Market Insights | Europe (Supplemental) | 2021

The COVID-19 pandemic will have a significant impact on ENT procedure volumes in the short term. Once the market stabilizes, however, ENT procedure volumes will grow slightly in Europe through 2029, due to growing developments in alternative treatment such as anitbiotics and continued effort of various associations to promote alternatives to surgery. However, ongoing adoption of premium-priced devices, and a general trend toward flexible endoscopy will result in slow growth of this market through 2029.

This Medtech 360 Report provides key market metrics for the GI endoscopy device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…